The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV

J Int Assoc Provid AIDS Care. 2019 Jan-Dec:18:2325958218821652. doi: 10.1177/2325958218821652.

Abstract

Objectives: To examine the risk of hypomagnesemia of HIV-positive patients adherent to proton pump inhibitors (PPIs).

Methods: A cohort study utilizing the Veterans Affairs Informatics and Computing Infrastructure was conducted on patients with (1) a complete antiretroviral therapy, (2) a serum magnesium measure during the study period, and (3) adherent to PPIs. Statistical analyses evaluated baseline characteristics between cohorts and a Cox proportional hazards model evaluating the association of hypomagnesemia while adjusting for baseline covariates.

Results: A total of 6047 patients met the study inclusion criteria, 329 patients in the PPI cohort and 5718 patients in the non-PPI cohort. The stratified Cox proportional hazards model results revealed that the risk of hypomagnesemia for the PPI cohort is 3.16 times higher compared to the non-PPI cohort (adjusted hazard ratio = 3.16, 95% confidence interval = 2.56-3.9).

Conclusions: Proton pump inhibitors medication usage in HIV-positive patients is associated with a higher risk of hypomagnesemia compared to non-PPI patients.

Keywords: HIV; hypomagnesemia; proton pump inhibitors.

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Humans
  • Magnesium / blood
  • Magnesium Deficiency / chemically induced*
  • Magnesium Deficiency / complications
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Proton Pump Inhibitors / adverse effects*
  • Retrospective Studies
  • Risk Factors
  • Veterans / statistics & numerical data*

Substances

  • Anti-HIV Agents
  • Proton Pump Inhibitors
  • Magnesium